triflupromazine has been researched along with Cerebral Arteriosclerosis in 2 studies
Triflupromazine: A phenothiazine used as an antipsychotic agent and as an antiemetic.
triflupromazine : A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(dimethylamino)propyl group at the N-10 position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danto, BL | 1 |
| Thiele, R | 1 |
2 other studies available for triflupromazine and Cerebral Arteriosclerosis
| Article | Year |
|---|---|
Triflupromazine versus pentylenetetrazol-nicotinic acid for treatment of chronic brain disease on a general-hospital psychiatric service.
Topics: Aged; Dementia; Female; Humans; Intracranial Arteriosclerosis; Male; Nicotinic Acids; Pentylenetetra | 1969 |
[Triflupromazine as a tranquilizer and antiemetic drug in internal medicine].
Topics: Antiemetics; Digitalis Glycosides; Gastritis; Humans; Intracranial Arteriosclerosis; Peptic Ulcer; S | 1965 |